Canada Gazette, Part I, Volume 149, Number 13: GOVERNMENT NOTICES

March 28, 2015

DEPARTMENT OF THE ENVIRONMENT

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication of final decision after screening assessment of a substance — Trisiloxane, octamethyl- (MDM), CAS RN (see footnote 1) 107-51-7 — specified on the Domestic Substances List (subsection 77(6) of the Canadian Environmental Protection Act, 1999)

Whereas Trisiloxane, octamethyl- is a substance on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the Screening Assessment conducted on the substance pursuant to section 74 of the Act is annexed hereby;

And whereas it is concluded that the substance does not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health propose to take no further action on the substance at this time under section 77 of the Act.

LEONA AGLUKKAQ
Minister of the Environment

RONA AMBROSE
Minister of Health

ANNEX

Summary of the Screening Assessment of Trisiloxane, octamethyl- (MDM)

Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA 1999), the Minister of the Environment and the Minister of Health conducted a screening assessment of Trisiloxane, octamethyl-, Chemical Abstracts Service Registry No. 107-51-7. This substance is referred to by its derived acronym, MDM. MDM was identified as a high priority for screening assessment and included in the Challenge initiative under the Chemicals Management Plan because it was found to meet the ecological categorization criteria for persistence, bioaccumulation potential and inherent toxicity to non-human organisms and was believed to be in commerce in Canada.

MDM was not considered to be a high priority for assessment of potential risks to human health, based upon application of the simple exposure and hazard tools developed by Health Canada for categorization of substances on the Domestic Substances List.

MDM is an organic substance that is primarily used as an ingredient in the preparation of polydimethylsiloxane (PDMS) polymers or mixtures. PDMS formulations containing MDM are in turn used as ingredients in industrial products, in consumer products such as cleaning and degreasing products, lubricants, diluents and solvents, and in cosmetics, including personal care products. (see footnote 2) MDM may also be added in its pure form to cosmetics, drugs, and natural health products and may be present as an impurity as a result of PDMS processing. MDM is not manufactured in Canada; however, imports for the calendar years 2005 and 2006 were in the range of 100 to 100 000 kg and 10 000 to 100 000 kg, respectively. The substance does not occur naturally in the environment.

Based on certain assumptions and reported use patterns, much of the MDM imported into Canada is expected to be exported out of the country in products, recycled during industrial use, or present in products that are eventually directed to landfills or incineration. Approximately half of the MDM used in Canada is expected to be released into the environment, with the majority of the emissions occurring to air and a small proportion (approximately 1%) being released to pre-treatment wastewaters. The high vapour pressure of MDM indicates that, when released into environmental media other than air, it will tend to volatilize out of these media and into air.

MDM present in air will undergo abiotic degradation through reaction with photochemically produced atmospheric hydroxyl radicals, with atmospheric half-lives of 6 to 9 days. Modelling predicts that MDM will have significant atmospheric transport potential but is unlikely to be deposited from air into water or soil in remote regions. Abiotic processes such as volatilization and hydrolysis are important removal processes for MDM in water and soil, with hydrolysis half-lives of 0.12 to 60.9 days and 1.5 to 120 days determined for water and soil, respectively. No degradation data was found for MDM in sediment, and a calculated biodegradation half-life of 365 days was determined using analogue data. This half-life indicates that MDM may remain for long periods in sediment. However, MDM has demonstrated a low potential for microbial biodegradation and, given the evidence for active abiotic degradation of the substance in both soil and water, it seems likely that an analysis of persistence in sediment based only on biodegradation data would underestimate the potential for removal in this medium.

MDM has demonstrated a significant bioconcentration capacity in laboratory testing with fish and may also have a significant potential to accumulate in organisms through dietary exposure. An empirical biomagnification factor (BMF) of less than 1 indicates that MDM is unlikely to transfer from one trophic level to the next highest level in the food web studied.

MDM has demonstrated a low hazard potential in aquatic species, with no adverse effects observed following prolonged exposures at concentrations up to the limit of water solubility. Adverse effects were reported in one of two laboratory studies conducted with the sediment species Lumbriculus variegatus. However, no adverse effects were seen in a second Lumbriculus study, nor were effects seen in laboratory testing with two other sediment species. The lowest effect level determined in testing with Lumbriculus is substantially higher than MDM levels measured or estimated to be present in the environment. No information was found on the potential for effects in terrestrial species; however, results obtained for a mechanistically similar compound suggest that MDM is not likely to be hazardous to terrestrial invertebrates or plants.

Monitoring data indicate that exposure levels of MDM in the environment are very low. The substance was below detection limits in surface water, soil and sediment samples, including those collected near potential MDM sources of release. MDM has been detected at low levels in some air samples and was also measured in some wastewater treatment plant influents and effluents, as well as in some pre-treatment industrial process waters and landfill leachates. However, the concentrations and frequency of occurrence are lower in effluents relative to influents collected at the same time and from the same treatment plants, indicating that wastewater treatment is effective at reducing the amount of MDM available to enter receiving waters. The results of quantitative risk quotient analyses conducted for surface waters and sediment determined that the highest predicted concentrations of MDM in the Canadian environment are much less than the experimentally determined no-effect levels.

Evidence for the active abiotic degradation of MDM, together with limited direct release of the substance to the environment and its effective removal at wastewater treatment plants, indicate that MDM will have a low exposure potential in the environment. On the basis of limited environmental presence, MDM is expected to pose a low risk to organisms. This low exposure and hazard potential indicate that there is a low risk of harm to organisms or to the broader integrity of the environment from MDM. It is therefore concluded that MDM does not meet the criteria under paragraph 64(a) or (b) of CEPA 1999 as it is not entering the environment in a quantity or concentration or under conditions that have or may have immediate or long-term harmful effects on the environment or its biological diversity, or that constitute or may constitute a danger to the environment on which life depends.

In terms of human health, the predominant source of exposure to MDM through environmental media is likely to be indoor air. Exposure of the general population to MDM may occur primarily through the use of cosmetics, including some personal care products.

Limited empirical health effects data was available for MDM. Liver, kidney and lung effects, as well as reduced body weight gain were observed in rats following repeated-dose exposure to MDM and its analogues. The margins between the upper-bounding estimates of exposure from environmental media and the use of products containing MDM and the critical effect levels in experimental animals are considered adequate to address uncertainties in the health effects and exposure databases.

On the basis of the adequacy of the margins between upper-bounding estimates of exposure to MDM and critical effect levels in experimental animals, it is concluded that MDM does not meet the criteria under paragraph 64(c) of CEPA 1999 as it is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health. Based on available information for human health considerations, it is concluded that MDM does not constitute a danger in Canada to human life or health.

Conclusion

It is concluded that MDM does not meet any of the criteria set out in section 64 of CEPA 1999.

The Screening Assessment for this substance is available on the Government of Canada's Chemical Substances Web site (www.chemicalsubstances.gc.ca).

[13-1-o]

DEPARTMENT OF THE ENVIRONMENT

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication of final decision after screening assessment of a substance — Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis[(trimethylsilyl)oxy]- (M4Q), CAS RN (see footnote 3) 3555-47-3 — specified on the Domestic Substances List (subsection 77(6) of the Canadian Environmental Protection Act, 1999)

Whereas Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3- bis[(trimethylsilyl)oxy]- is a substance on the Domestic Substances List identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the Screening Assessment conducted on the substance pursuant to section 74 of the Act is annexed hereby;

And whereas it is concluded that the substance does not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health propose to take no further action on the substance at this time under section 77 of the Act.

LEONA AGLUKKAQ
Minister of the Environment

RONA AMBROSE
Minister of Health

ANNEX

Summary of the Screening Assessment of Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis[(trimethylsilyl)oxy]- (M4Q)

Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA 1999), the Minister of the Environment and the Minister of Health conducted a screening assessment of Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis[(trimethylsilyl)oxy]-, Chemical Abstracts Service Registry No. 3555-47-3. This substance is referred to by its derived acronym, M4Q. M4Q was identified as a high priority for screening assessment and included in the Challenge initiative under the Chemicals Management Plan because it was found to meet the ecological categorization criteria for persistence, bioaccumulation potential and inherent toxicity to non-human organisms and was believed to be in commerce in Canada.

M4Q was not considered to be a high priority for assessment of potential risks to human health, based upon application of the simple exposure and hazard tools developed by Health Canada for categorization of substances on the Domestic Substances List.

M4Q is an organic substance that is formed in low concentrations as an impurity during the production of certain siloxane products and intermediates. The substance does not occur naturally in the environment. M4Q is reported to be present at low levels as a reaction by-product or impurity in silicon-based adhesives, sealants, processing intermediates and anti-adhesive agents. The substance may also occur at low levels as an impurity in fillers, finishing agents, lubricants and lubricant additives, antifoaming agents, and viscosity adjustors in consumer products such as paint and coating additives. M4Q is also present as an impurity in cosmetics.

Responses to notices published under section 71 of CEPA 1999 indicated that quantities of M4Q imported into Canada were in the range of 1 001 to 100 000 kg for 2005 and 1 000 to 10 000 kg for 2006. In all instances of import, the substance was reported to be present as an impurity in an end-use product. M4Q is formed as a reaction by-product; therefore, no manufacturing activities are associated with this substance.

Based on certain assumptions and reported use patterns in Canada, most M4Q is expected to be present in products directed to landfill following industrial, consumer or commercial use. Release to wastewater during industrial applications may also occur, with proportionally smaller losses through volatilization from consumer and commercial products. Information indicates that during processing operations where M4Q is formed, the substance becomes bound within the silicone matrix of the product, and that this limits but does not completely eliminate the potential for release into the environment.

The physical and chemical properties of M4Q indicate that, when released into the environment, the substance can be expected to distribute primarily into air, although it may also distribute into sediment when released into water.

No empirical degradation data was found for M4Q, and modelled estimates for M4Q, as well as empirical and modelled data for other chemically similar volatile methylsiloxanes (VMSs), were used to evaluate the potential for environmental persistence. The atmospheric half-life of 5.9 days predicted for M4Q is comparable with values derived for other VMSs. Modelling predicts that M4Q will have significant atmospheric transport potential but is not likely to be deposited to water or soil in remote regions.

Modelled estimates predict that M4Q will biodegrade slowly in the environment, which is consistent with data available for other VMSs. However, the preponderance of data for other VMSs such as the linear VMS, Trisiloxane, octamethyl- (MDM), and the cyclic VMS, D4 and D5, indicates that these substances hydrolyze readily in water and soil. No empirical degradation data was found for VMSs in sediment. The analysis of the potential for persistence was based on modelled and calculated biodegradation half-lives, which indicate slow removal rates and, therefore, the potential to remain for long periods in this environmental medium. However, the other VMSs examined in the assessment have demonstrated low potential for microbial biodegradation and, given the evidence for active abiotic degradation of these substances in both soil and water, it seems likely that an analysis of persistence in sediment based only on biodegradation data would underestimate the potential for removal in this medium.

No experimental bioaccumulation factor (BAF) or bioconcentration factor (BCF) data were found for M4Q. Based on the chemical properties of the substance, as well as BCF data for acceptable analogue substances, it is likely that M4Q will have some capacity for uptake into aquatic organisms via the surrounding water medium. In addition, BAF estimates calculated for M4Q determined that the substance may have significant potential to accumulate in organisms through dietary exposure. While M4Q may have the potential to accumulate in individual organisms, an empirical biomagnification factor (BMF) of less than 1 indicates that it is unlikely to transfer from one trophic level to the next highest trophic level in the food web studied.

M4Q has demonstrated low hazard potential in aquatic species, with no adverse effects observed following prolonged exposures at concentrations up to the limit of water solubility. Modelled estimates also predict no effects in fish, Daphnia, mysid shrimp and algae. Adverse effects were reported in one sediment toxicity study. No information was found on the potential for effects in terrestrial species; however, results obtained for a mechanistically similar compound suggest that M4Q is not likely to be hazardous to terrestrial invertebrates or plants.

Monitoring data indicate that exposure levels of M4Q in the environment are very low. The substance was below detection limits in bottom sediments and biota samples, including those collected near potential M4Q sources of release. M4Q has been detected at low concentrations in a small number of suspended particulate matter samples, as well as in some wastewater treatment plant influents and effluents, pre-treatment industrial process waters and landfill leachates. However, the concentrations and frequency of occurrence are lower in effluents relative to influents collected at the same time and from the same treatment plant, indicating that wastewater treatment is effective at reducing the amount of M4Q available to enter receiving waters. The results of quantitative risk quotient analyses conducted for surface waters and sediment determined that the highest predicted concentrations of M4Q in the Canadian environment are much less than experimentally determined no-effect levels.

The low presence of M4Q in products as well as limitations to its direct release from these products and evidence for effective removal at wastewater treatment plants indicate that M4Q will have low exposure potential in the environment. This low exposure, together with the observed lack of toxicity in laboratory testing conducted at concentrations up to the maximum water solubility or saturation limit of the substance, indicates that there is a low risk of harm to organisms or to the broader integrity of the environment from M4Q. It is therefore concluded that M4Q does not meet the criteria under paragraph 64(a) or (b) of CEPA 1999 as it is not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity, or that constitute or may constitute a danger to the environment on which life depends.

In terms of human health, exposure of the general population to M4Q is expected to occur mainly through use of paints, coatings, and cosmetics.

Limited empirical health effects data was available for M4Q. Health effects data for analogues indicate potential effects mainly on the liver in experimental animals following repeated-dose exposure. The margins between the upper-bound estimates of exposure from environmental media (predominantly air) and from the use of consumer products (alkyd coating) and cosmetics containing M4Q and the critical effect levels in experimental animals are considered adequate to address uncertainties in the health effects and exposure databases.

On the basis of the adequacy of the margins between upper-bound estimates of exposure to M4Q and critical effect levels in experimental animals, it is concluded that M4Q is a substance that does not meet the criteria under paragraph 64(c) of CEPA 1999 as it is not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

Conclusion

It is concluded that M4Q does not meet any of the criteria set out in section 64 of CEPA 1999.

The Screening Assessment for this substance is available on the Government of Canada's Chemical Substances Web site (www.chemicalsubstances.gc.ca).

[13-1-o]

DEPARTMENT OF HEALTH

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions, undertakings and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of the decisions of the screening officer, respecting each claim for exemption and the relevant material safety data sheet (MSDS) and (where applicable) the label, listed below.

In accordance with section 20 of the Hazardous Materials Information Review Act, a claimant or any affected party, as defined, may appeal a decision or order of a screening officer. An affected party may also appeal an undertaking in respect of which a notice has been published in the Canada Gazette. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered, along with the fee prescribed by section 12 of the Hazardous Materials Information Review Regulations, within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Workplace Hazardous Materials Bureau, 269 Laurier Avenue West, 4th Floor, Ottawa, Ontario K1A 0K9.

ROSSLYNN MILLER-LEE
Chief Screening Officer

On February 11, 2015, the Hazardous Products Act (HPA) was amended, and the Controlled Products Regulations (CPR) and the Ingredient Disclosure List were repealed and replaced with the new Hazardous Products Regulations (HPR). The revised legislation (HPA/HPR) is referred to as WHMIS 2015 and the former legislation (HPA/CPR) is referred to as WHMIS 1988.

Transitional provisions allow compliance with either WHMIS 1988 or WHMIS 2015 for a specified period of time. All claims for exemption in this publication were filed and evaluated in accordance with the provisions of WHMIS 1988.

There were no written representations from affected parties with respect to any of the below-mentioned claims for exemption and related MSDSs or labels.

Each of the claims for exemption listed in the table below was found to be valid, except for Registry Numbers (RNs) 8682 and 8908, which were found to be invalid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations.

Claimant Product Identifier Registry Number Date of Decision
Hilti Inc., Tulsa, Oklahoma HIT-HY 70 8503 2014-10-27
CRI/Criterion Inc., Houston, Texas CRITERION CENTERA™ DN-3651 CATALYST 8617 2014-06-12
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina QPR®-H2C 8658 2014-07-02
Champion Technologies ULC, Calgary, Alberta Flotron® M-269 8667 2014-07-11
BASF Canada Inc., Florham Park, New Jersey XPDL 590 8682 2014-07-03
Nalco Canada Company, Burlington, Ontario 3D TRASAR® 3DT208 8686 2014-09-15
Calfrac Well Services Ltd., Calgary, Alberta DWP-421 8725 2014-10-16
Graffiti Solutions Inc., North Saint Paul, Minnesota Elephant Snot 8730 2014-09-15
Graffiti Solutions Inc., North Saint Paul, Minnesota Shadow Max 8731 2014-09-30
Momentive Performance Materials, Markham, Ontario NuWet* 237 hydrophilic finish 8802 2014-10-27
Momentive Performance Materials, Markham, Ontario Niax® catalyst C-255 8803 2014-10-07
Reichhold, Inc., Research Triangle Park, North Carolina BECKOSOL AQ ® 510 8807 2014-09-05
Air Products and Chemicals, Inc., Allentown, Pennsylvania TOMADRY® DAB SURFACTANT 8841 2014-07-02
DuPont Electronic Technologies - MCM, Research Triangle Park, North Carolina 5880 8859 2014-04-14
Nalco Canada Company, Burlington, Ontario NALCO® VX10987 8869 2014-09-09
Nalco Canada Company, Burlington, Ontario NALCO® VX10902 8874 2014-07-11
Baker Petrolite Corporation, Sugar Land, Texas TOLAD™ 3060 ADDITIVE 8880 2014-07-14
3M Canada Company, London, Ontario SCOTCHKOTE 413 SPRAY GRADE FUSION BANDED EPOXY COATING 8881 2014-07-02
Afton Chemical Corporation, Richmond, Virginia HiTEC® 397G Performance Additive 8884 2014-07-30
Nalco Canada Company, Burlington, Ontario pHREEdom® 5200M 8886 2014-08-12
Nalco Canada Company, Burlington, Ontario NALCO® OS2190 8887 2014-08-12
GE Water & Process Technologies Canada, Trevose, Pennsylvania INHIBITOR VCS2000 8893 2014-08-15
GE Water & Process Technologies Canada, Trevose, Pennsylvania PETROFLO 20Y3450 8895 2014-08-21
Chevron Oronite Company LLC, Bellaire, Texas LUBAD® 1817 8896 2014-07-30
Stepan Company, Northfield, Illinois TOXIMUL 8362 8898 2014-07-11
Chevron Oronite Company LLC, Bellaire, Texas OLOA® 55508 8900 2014-07-30
3M Canada Company, London, Ontario Scotchkote 626-155 Fusion B 8901 2014-07-14
ZEC Lubrication Inc., Ottawa, Ontario AC-XL 8902 2014-10-16
Arkema Canada Inc., Burlington, Ontario LUPEROX® RTM 8903 2014-09-03
Rohm and Haas Canada LP, West Hill, Ontario PARALOID™EXL-2314 IMPACT MODIFIER 8904 2014-07-18
PMC Organometallix, Mount Laurel, New Jersey THERMOLITE® 176 8905 2014-07-10
PMC Organometallix, Mount Laurel, New Jersey THERMOLITE® 140 8907 2014-07-10
Innospec Fuel Specialties LLC, Richmond, British Columbia DDA-3525 IA2 8908 2014-07-09
Cytec Industries Inc., Atlanta, Georgia CYASORB® 390C Stabilizer 8910 2014-07-02
Multi-Chem Production Chemicals Co., Calgary, Alberta RockOn ™ MX 5-3120 8911 2014-07-03
Multi-Chem Production Chemicals Co., Calgary, Alberta MC SS-5041 8912 2014-07-09
Multi-Chem Production Chemicals Co., Calgary, Alberta MC MX 2-2822 8913 2014-07-09
Nalco Canada Company, Burlington, Ontario DETACK EC9444D 8914 2014-07-04
Nalco Canada Company, Burlington, Ontario NALCO® VX11001 8915 2014-07-08
Nalco Canada Company, Burlington, Ontario DETACK EC9440D 8916 2014-07-09
Nalco Canada Company, Burlington, Ontario DETACK EC9451D 8918 2014-07-09
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 81 radiation curing resins 8919 2014-07-21
Dow Chemical Canada ULC, Calgary, Alberta DOW™ IC-210 GAS CONDITIONING CHELANT 8920 2014-07-21
Dow Chemical Canada ULC, Calgary, Alberta DOW™ CA-2003 Sulfur Conditioning Additive 8921 2014-10-07
Halliburton Energy Services, Inc., Mississauga, Ontario AS-9 ANTI-SLUDGING AGENT 8923 2014-09-09
Halliburton Energy Services, Inc., Mississauga, Ontario AS-7 ANTI-SLUDGING AGENT 8924 2014-08-01
Halliburton Energy Services, Inc., Mississauga, Ontario A-SPERSE 8925 2014-07-14
Halliburton Energy Services, Inc., Mississauga, Ontario 19N 8926 2014-07-14
Halliburton Energy Services, Inc., Mississauga, Ontario CL-11 CROSSLINKER 8927 2014-07-15
Halliburton Energy Services, Inc., Mississauga, Ontario CL-41 8928 2014-10-02
Halliburton Energy Services, Inc., Mississauga, Ontario CleanLink 8929 2014-10-27
Halliburton Energy Services, Inc., Mississauga, Ontario FDP-S1047-12 8930 2014-09-08
Halliburton Energy Services, Inc., Mississauga, Ontario BC-200 UC 8931 2014-08-29
Halliburton Energy Services, Inc., Mississauga, Ontario CAT-3 ACTIVATOR 8932 2014-07-29
Halliburton Energy Services, Inc., Mississauga, Ontario Cla-Web™ 8933 2014-08-06
Halliburton Energy Services, Inc., Mississauga, Ontario Clayfix II Plus 8934 2014-08-11
Halliburton Energy Services, Inc., Mississauga, Ontario CLAYFIX II MATERIAL 8935 2014-08-11
Halliburton Energy Services, Inc., Mississauga, Ontario ES-5 PROPLOK SURFACTANT 8937 2014-07-18
Halliburton Energy Services, Inc., Mississauga, Ontario FDP-S821-06 8938 2014-07-18
Halliburton Energy Services, Inc., Mississauga, Ontario G-SPERSE 8939 2014-07-16
Halliburton Energy Services, Inc., Mississauga, Ontario HAI-404M™ 8940 2014-08-20
Halliburton Energy Services, Inc., Mississauga, Ontario GasPerm 1000™ 8941 2014-07-17
Halliburton Energy Services, Inc., Mississauga, Ontario GasPerm 1100 8942 2014-08-29
Halliburton Energy Services, Inc., Mississauga, Ontario HAI-OS ACID INHIBITOR 8943 2014-09-10
Halliburton Energy Services, Inc., Mississauga, Ontario HC-2 8944 2014-08-11
Halliburton Energy Services, Inc., Mississauga, Ontario HII-500M CORROSION INHIBITOR 8945 2014-08-11
Halliburton Energy Services, Inc., Mississauga, Ontario HZ-20 8946 2014-08-14
Halliburton Energy Services, Inc., Mississauga, Ontario LCA-1 8947 2014-08-29
Halliburton Energy Services, Inc., Mississauga, Ontario MO-86M 8948 2014-07-18
Halliburton Energy Services, Inc., Mississauga, Ontario MUSOL A SOLVENT 8949 2014-07-18
Halliburton Energy Services, Inc., Mississauga, Ontario PARASPERSE CLEANER 8950 2014-09-29
Halliburton Energy Services, Inc., Mississauga, Ontario PEN-88M 8951 2014-08-20
Halliburton Energy Services, Inc., Mississauga, Ontario SPERSE-ALL M 8953 2014-09-09
Halliburton Energy Services, Inc., Mississauga, Ontario SSO-21M WINTERIZED 8954 2014-09-09
Halliburton Energy Services, Inc., Mississauga, Ontario WS-36 EMULSIFYING AGENT 8955 2014-09-17
Halliburton Energy Services, Inc., Mississauga, Ontario WS-36M 8956 2014-09-26
Halliburton Energy Services, Inc., Mississauga, Ontario MO-85M 8957 2014-07-29
Nalco Canada Company, Burlington, Ontario NALCO® EC1630A 8958 2014-09-09
Hydro Technologies (Canada) Inc., Québec, Quebec HY BRITE® DB-1300 8959 2014-08-21
Trican Well Service Ltd., Calgary, Alberta TXP-17 8960 2014-07-25
Nalco Canada Company, Burlington, Ontario CLEAN N COR® EC1579W 8963 2014-08-26
Trican Well Service Ltd., Calgary, Alberta TXP-18 8964 2014-10-16
Babcock-Hitachi K.K., Kure-Shi, Hiroshima-Ken H3-1 8965 2014-07-31
W-TECH Technologies Ltd., Vancouver, British Columbia MD800 8966 2014-08-05
Chevron Oronite Company LLC, Bellaire, Texas OLOA® 40814 8967 2014-09-08
Chevron Oronite Company LLC, Bellaire, Texas MAR501S 8968 2014-09-08
Nalco Canada Company, Burlington, Ontario NALCO® VX10986 8969 2014-10-22
Calfrac Well Services Ltd., Calgary, Alberta DAP-634 8970 2014-10-28
Nalco Canada Company, Burlington, Ontario BREAXIT® SP177 8971 2014-08-27
Nalco Canada Company, Burlington, Ontario BREAXIT® SP354 8972 2014-08-18
SSC Inc., Hamilton, Ontario SCL 802IC 8973 2014-08-25
Nalco Canada Company, Burlington, Ontario NALCO® EC9453A 8975 2014-09-09
Halliburton Energy Services, Inc., Mississauga, Ontario LGC-VI UC 8977 2014-09-29
Halliburton Energy Services, Inc., Mississauga, Ontario FDP-S867A-07 8978 2014-09-24
Halliburton Energy Services, Inc., Mississauga, Ontario CAS-1 8979 2014-09-30
Halliburton Energy Services, Inc., Mississauga, Ontario MO-85 LP 8980 2014-09-30
Halliburton Energy Services, Inc., Mississauga, Ontario D-AIR 3000W 8981 2014-10-03
Nalco Canada Company, Burlington, Ontario NALCO® EC1632A 8982 2014-10-01
Nalco Canada Company, Burlington, Ontario ASP® FNE200 8983 2014-10-17
Evonik Corporation, Parsippany, New Jersey Dynasylan® HYDROSIL 1151 8984 2014-08-29
Trican Well Service Ltd., Calgary, Alberta SS-5 8985 2014-08-25
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 3708 radiation curing resins 8992 2014-07-30
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 860 radiation curing resins 8993 2014-07-31
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 450 radiation curing resins 8994 2014-08-25
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 83 radiation curing resins 8995 2014-07-30
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 168 radiation curing resins 8996 2014-07-30
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 438 radiation curing resins 8999 2014-08-11
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 220 radiation curing resins 9000 2014-10-21
Allnex Canada Inc., (c/o Goodmans, LLP), Paramus, New Jersey EBECRYL® 265 radiation curing resins 9001 2014-09-29
Weatherford, Calgary, Alberta PChem™ BS 648 9004 2014-09-23
Weatherford, Calgary, Alberta PChem™ IS 48 9005 2014-09-23
Engenium Chemicals Corporation, Calgary, Alberta HydroCOR 9007 2014-10-27
Hydro Technologies (Canada) Inc., Québec, Quebec HY BRITE®RBC-8000 9017 2014-08-21
Hydro Technologies (Canada) Inc., Québec, Quebec HY BRITE® CBR-1308 9047 2014-08-21
BASF Canada Inc., Florham Park, New Jersey Pluracoat® Performa CF 20 9050 2014-07-09
Hydro Technologies (Canada) Inc., Québec, Quebec HY BRITE® RA-1204 9183 2014-08-21
Win Manuco Ltd., Burlington, Ontario ALB 9207 2014-08-20
MeadWestvaco Corporation - Specialty Chemicals Division, North Charleston, South Carolina INDULIN® 206 9251 2014-09-29

The subject of the claim on which the screening officer issued a decision for the following claims is different from the subject of the claim that was published in the Notice of Filing.

Registry Number Notice of Filing Publication Date Original Subject of the Claim Revised Subject of the Claim
8658 2012-09-22 C.i. of three ingredients C.i. and C. of three ingredients
8667 2012-09-22 C.i. and C. of one ingredient and the name of a toxicological study C.i. and C. of two ingredients
8725 2012-12-01 C.i. and C. of two ingredients C.i. and C. of three ingredients
8730 2012-12-01 C.i. and C. of three ingredients C.i. of five ingredients
8731 2012-12-01 C.i. and C. of three ingredients C.i. of four ingredients
8874 2013-09-14 C.i. of six ingredients C.i. of seven ingredients
8886 2013-09-14 C.i. of one ingredient C.i. of two ingredients
8895 2013-09-14 C.i. and C. of three ingredients C.i. and C. of two ingredients
8902 2013-09-14 C.i. and C. of one ingredient C.i. and C. of three ingredients
8904 2013-09-14 C.i. and C. of three ingredients C.i. of two ingredients
8913 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8915 2013-09-14 C.i. and C. of three ingredients C.i. of three ingredients
8916 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8918 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8923 2013-09-14 C.i. and C. of one ingredient C.i. and C. of two ingredients
8929 2013-09-14 C.i. of two ingredients C.i. and C. of one ingredient
8931 2013-09-14 C.i. and C. of one ingredien C.i. and C. of two ingredients
8933 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient/
8934 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8935 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8940 2013-09-14 C.i. and C. of two ingredients C.i. and C. of five ingredients
8941 2013-09-14 C.i. and C. of two ingredients C.i. and C. of three ingredients
8942 2013-09-14 C.i. and C. of two ingredients C.i. and C. of four ingredients
8948 2013-09-14 C.i. and C. of two ingredients C.i. and C. of three ingredients
8950 2013-09-14 C.i. of one ingredient C.i. and C. of two ingredients
8951 2013-09-14 C.i. and C. of one ingredient C.i. and C. of three ingredients
8953 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8954 2013-09-14 C.i. and C. of one ingredient C.i. of two ingredients
8955 2013-09-14 C.i. and C. of one ingredient C.i. and C. of two ingredients
8956 2013-09-14 C.i. and C. of one ingredient C.i. and C. of three ingredients
8958 2013-09-14 C.i. and C. of six ingredients C.i. of eight ingredients
8963 2013-09-14 C.i. and C. of five ingredients C.i. of five ingredients
8967 2013-09-14 C.i. and C. of two ingredients C.i. of two ingredients
8968 2013-09-14 C.i. and C. of two ingredients C.i. of two ingredients
8969 2013-09-14 C.i. and C. of six ingredients C.i. of eight ingredients
8971 2013-09-14 C.i. and C. of one ingredient C.i. of four ingredients
8975 2013-09-14 C.i. and C. of three ingredients C.i. of three ingredients
8978 2013-09-14 C.i. and C. of one ingredient C.i. and C. of two ingredients
8982 2013-09-14 C.i. and C. of six ingredients C.i. of seven ingredients
8983 2013-09-14 C.i. and C. of two ingredients C.i. of two ingredients
8992 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
8993 2013-09-14 C.i. and C. of two ingredients C.i. of two ingredients
8995 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient
9000 2013-09-14 C.i. and C. of one ingredient C.i. of one ingredient

Note: C.i. = Chemical identity and C. = concentration.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDSs in respect of the claims bearing Registry Numbers 8807, 8880, 8887, 8905, 8907, 8914, 8920, 8932, 8939, 8959, 8960, 8964, 8985, 8999, 9017, 9047, 9050, 9183, 9207 and 9251 complied with the requirements of the relevant legislation.

In all cases where the MSDS or the label was determined not to be in compliance with the relevant legislation, pursuant to subsection 16.1(1) of the Hazardous Materials Information Review Act, the claimant was given 30 days to provide the screening officer with a signed undertaking accompanied by the MSDS or the label amended as necessary.

CLAIMS FOR WHICH THE SCREENING OFFICER WAS SATISFIED THAT THE CLAIMANT HAD TAKEN THE MEASURES SET OUT IN THE UNDERTAKING

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that has been disclosed on the relevant MSDS or label in compliance with an undertaking and the date on which the notice referred to in subsection 16.1(3) of the Act was issued.

RN: 8617 Date: 2014-11-07

The claimant had been advised to amend certain aspects of the content, format and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose a WHMIS acceptable concentration range for the hazardous ingredient “aluminum oxide”.
  2. Disclose that acute ingestion of the hazardous ingredient “molybdenum oxide” has been shown to cause central nervous system effects in laboratory animals.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed and that medical attention must be obtained immediately.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  6. Add oxides of carbon and oxides of nitrogen to the list of hazardous decomposition products.
  7. Disclose an LD50 (oral, rat) value of 9 990 mg/kg for the hazardous ingredient “nickel oxide”.
  8. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “substituted amine” in an acceptable manner.
  9. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

RN: 8658 Date: 2014-11-19

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of the confidential hazardous ingredient “aliphatic carboxylic acids”.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. Disclose for “alkyl polyamine mixture” an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 for the confidential hazardous ingredient “component B”, an ACGIH TLV–TWA Exposure Limit of 1 ppm for the confidential hazardous ingredient “component C” and an AIHA WEEL–TWA Exposure Limit of 1 ppm for the confidential hazardous ingredient “component H”, with a skin notation.
  5. Disclose an LD50 (oral) value, an LC50 (aerosol) value and an LD50 (dermal) value for the confidential hazardous ingredient “alkyl polyamine mixture” in an acceptable manner.
  6. Disclose that the confidential hazardous ingredient “alkyl polyamine mixture” has been shown to cause mutagenic effects in bacteria, in vitro.
  7. Disclose that the confidential hazardous ingredient “alkyl polyamine mixture” has been classified as a suspected human carcinogen (A3) by the ACGIH.

RN: 8667 Date: 2014-08-27

The claimant had been advised to amend certain aspects of the format and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity of the confidential hazardous ingredient “heterocyclic quaternary amine”.
  2. Add oxides of nitrogen to the list of hazardous combustion products.
  3. Disclose an LD50 (oral, rat) value of 7 050 mg/kg for the hazardous ingredient “heavy aromatic solvent naphtha”.
  4. Disclose that the hazardous ingredient “xylene” has been shown to cause skin sensitization in humans.
  5. Disclose that inhalation of the hazardous ingredient “xylene” has been shown to cause fetotoxic effects and developmental toxicity in the absence of maternal toxicity in laboratory animals.

RN: 8686 Date: 2014-10-15

The claimant had been advised to amend certain aspects of the content of the MSDS and further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, female rat) value of 566 mg/kg and an LC50 (aerosol, rat, 4 hours) value of 1.43 g/m3 for the hazardous ingredient “benzotriazole”.
  2. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8725 Date: 2014-11-18

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity and percent concentration for the confidential hazardous ingredient “fatty amine III” in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 15–20 minutes.
  3. Disclose an LD50 (dermal, rabbit) value of 8.0 mL/kg for the hazardous ingredient “2-propanol”.
  4. Disclose that the hazardous ingredient “2-propanol” has been shown to cause teratogenic and embryotoxic effects in the presence of maternal toxicity in laboratory animals.

RN: 8730 Date: 2014-10-24

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredients “glycinol”, “silica” and “mineral base” in an acceptable manner.
  2. Disclose an ACGIH TLV–STEL Exposure Limit of 6 ppm for the confidential hazardous ingredient “glycinol”.
  3. Disclose on the MSDS the presence of an additional confidential hazardous ingredient, “mineral salt of 9-octadecenoic acid”, together with its percent concentration, in an acceptable manner.
  4. Add oxides of nitrogen to the list of hazardous decomposition products.
  5. Disclose ingestion as a route of entry.
  6. Disclose an LD50 value for the controlled product in an acceptable manner.
  7. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 60 minutes.

RN: 8731 Date: 2014-11-03

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “inorganic base”.
  2. Disclose an ACGIH TLV–STEL Exposure Limit of 6 ppm for the confidential hazardous ingredient “olamine”.
  3. Disclose on the MSDS the presence of an additional confidential hazardous ingredient, “potassium soap salt”, together with its percent concentration, in an acceptable manner.
  4. Add oxides of nitrogen to the list of hazardous decomposition products.
  5. Disclose ingestion as a route of entry.
  6. Disclose an LD50 value for the controlled product in an acceptable manner.
  7. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 60 minutes.
  8. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.

RN: 8802 Date: 2014-11-05

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose inhalation as a route of entry.

RN: 8803 Date: 2014-10-27

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose skin contact and inhalation as routes of entry.
  2. Add oxides of nitrogen to the list of hazardous combustion products.
  3. Disclose an LD50 (oral, rat) value of 700 mg/kg for the confidential hazardous ingredient “tertiary amine II”.
  4. Disclose an LC50 (rat, 6 hours) value of 117 ppm for the hazardous ingredient “bis(2-dimethylaminoethyl)ether”.
  5. Disclose that an ingredient has been shown to cause teratogenic/fetotoxic/embryotoxic effects in the absence of maternal toxicity in laboratory animals.

RN: 8869 Date: 2014-10-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. Disclose an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “aliphatic alcohol 1” in an acceptable manner.
  3. Disclose an LC50 (vapour, male rat, 4 hours) value of 117 mg/L for the confidential hazardous ingredient “aliphatic alcohol 2”.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  5. Disclose a statement to the effect that the product should be stored in a well-ventilated, cool and dry location.
  6. Disclose that the confidential hazardous ingredients “substituted alcohol”, “aliphatic alcohol 1” and “aliphatic alcohol 2” have been shown to cause developmental toxicity in the presence of maternal toxicity in laboratory animals.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8874 Date: 2014-08-15

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. Disclose the generic chemical identity for the hazardous ingredient “phosphoric acid esters”, together with its percent concentration, in an acceptable manner.
  3. Disclose an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “organic sulfur compound” in an acceptable manner.
  4. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “oxyalkylate” in an acceptable manner.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  6. Add oxides of nitrogen, oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.
  7. Disclose a statement to the effect that the product should be stored in a well-ventilated, cool and dry location.

RN: 8881 Date: 2014-07-16

The claimant had been advised to amend the MSDS as indicated below.

  1. Add hydrogen chloride to the list of hazardous decomposition products on the MSDS.
  2. Disclose that chronic inhalation of an ingredient has been shown to cause lung fibrosis in laboratory animals.

RN: 8886 Date: 2014-09-12

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional confidential hazardous ingredient, “acrylate polymer”, together with its percent concentration, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

RN: 8893 Date: 2014-09-15

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause skin corrosion in laboratory animals.
  2. Disclose that an ingredient has been shown to cause reproductive and developmental toxicity in laboratory animals.
  3. Disclose an LD50 (oral, rat) value of 735 mg/kg for the hazardous ingredient “benzotriazole, methyl, sodium salt”.
  4. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and E.

RN: 8895 Date: 2014-09-23

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that a hazardous ingredient has been shown to cause eye corrosion.
  2. Disclose an LD50 (oral, rat) value of 7 050 mg/kg for the hazardous ingredient “solvent naphtha, petroleum, heavy aromatic”.
  3. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “amine oxide radical” in an acceptable manner.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give 2–8 fluid ounces of water or milk.
  6. Add oxides of nitrogen to the list of hazardous combustion products.
  7. Disclose an ACGIH TLV–TWA Exposure Limit for the confidential hazardous ingredient “glycol ether” in an acceptable manner.

RNs: 8896 and 8900 Date: 2014-08-29

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, “diphenylamine”, together with its percent concentration and CAS registry number, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 20 minutes.

RN: 8898 Date: 2014-08-01

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that a hazardous ingredient has been shown to cause eye corrosion.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. Disclose the AIHA WEEL–TWA Exposure Limit value of 10 mg/m3 for the confidential hazardous ingredient “glycol (2)”.
  5. Disclose an LD50 (oral, female rat) value of 12 570 mg/kg and an LD50 (dermal, rabbit) value of 11.2 L/kg for the confidential hazardous ingredient “glycol (2)”.
  6. Disclose that ingestion of an ingredient has been shown to cause central nervous system effects and kidney and neurological effects.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8901 Date: 2014-07-29

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 15–20 minutes.
  2. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.
  3. Disclose an ACGIH TLV–TWA Exposure Limit of 10 mg/m3 for the confidential hazardous ingredient “pigment additive”.
  4. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 8902 Date: 2014-11-19

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of >500 mg/kg for the confidential hazardous ingredient “carboxylic acid”.

RN: 8903 Date: 2014-09-09

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add oxides of nitrogen to the list of hazardous combustion products.
  2. Disclose that an ingredient has been shown to cause mutagenic effects in mammalian cells, in vitro.

RN: 8904 Date: 2014-08-15

The claimant had been advised to amend the MSDS as indicated below.

  1. Add oxides of carbon to the list of hazardous combustion products.

RN: 8910 Date: 2014-07-21

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add hydrogen chloride to the list of hazardous decomposition products on the MSDS.

RN: 8911 Date: 2014-10-01

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that chronic exposure to the hazardous ingredient “methyl alcohol” has been shown to cause deleterious effects to the optic nerve and to the eye.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8912 Date: 2014-10-01

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that chronic exposure to the hazardous ingredient “methyl alcohol” has been shown to cause deleterious effects to the optic nerve and to the eye.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 15–20 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. Add hydrogen chloride to the list of hazardous combustion products.
  5. Disclose an Alberta TWA Exposure Limit of 200 ppm and an Alberta STEL Exposure Limit of 400 ppm for the hazardous ingredient “isopropyl alcohol”.
  6. Disclose an LD50 (dermal, rabbit) value of 8.00 mL/kg for the hazardous ingredient “isopropyl alcohol”.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8913 Date: 2014-10-01

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that chronic exposure to the hazardous ingredient “methyl alcohol” has been shown to cause deleterious effects to the optic nerve and to the eye.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8915 Date: 2014-08-19

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Add hydrogen chloride to the list of hazardous combustion products.

RNs: 8916 and 8918 Date: 2014-08-11

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give plenty of water to drink.

RN: 8919 Date: 2014-09-26

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye contact, disclose that medical attention must be obtained immediately.

RN: 8921 Date: 2014-11-12

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that the hazardous ingredient “isopropanol” has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
  2. Disclose an LD50 (oral, rat) value and an LD50 (dermal, rabbit) value for the hazardous ingredient “isopropanol” in an acceptable manner.
  3. Disclose an LD50 (oral, rat) value and an LC50 (aerosol, rat, 4 hours) value for the confidential hazardous ingredient “polyether alkylphenol, branched” in an acceptable manner.

RN: 8923 Date: 2014-09-09

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity and percent concentration for the confidential hazardous ingredient “sulfated salt” in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water to drink.
  4. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  5. Disclose the skin notation for the ACGIH TLV–TWA and OSHA Exposure Limit for the hazardous ingredient “morpholine” in an acceptable manner.
  6. Disclose an ACGIH TLV–TWA Exposure Limit of 50 ppm and an ACGIH TLV–STEL Exposure Limit of 100 ppm for the hazardous ingredient “1-methoxy-2-propanol”.
  7. Disclose ingestion as a route of entry.
  8. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.
  9. Disclose that an ingredient has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
  10. Disclose an LD50 (oral, male rat) value of 3 739 mg/kg for the hazardous ingredient “1-methoxy-2-propanol”.

RN: 8924 Date: 2014-09-12

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come in contact with an ignition source.
  3. Disclose the skin notation for the ACGIH TLV–TWA and OSHA Exposure Limit for the hazardous ingredient “morpholine” in an acceptable manner.
  4. Disclose ingestion as a route of entry.
  5. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 8925 Date: 2014-08-15

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the WHMIS classification D1B, if the WHMIS classifications are stated on the MSDS, and the WHMIS D1 pictogram, if WHMIS pictograms are shown on the MSDS.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source.
  4. Disclose the skin notation for the ACGIH TLV–TWA and OSHA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  5. Disclose ingestion as a route of entry.

RN: 8926 Date: 2014-08-15

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.
  2. Add hydrogen chloride to the list of hazardous combustion products.
  3. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source and that the product should be stored in a well-ventilated, cool and dry location.
  4. Disclose the skin notation for the ACGIH TLV–TWA and OSHA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  5. Disclose ingestion as a route of entry.
  6. Disclose an LD50 (dermal, rabbit) value of 6 280 mg/kg for the hazardous ingredient “isopropanol”.

RN: 8927 Date: 2014-08-18

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.
  2. Add oxides of nitrogen to the list of hazardous combustion products.
  3. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source and that the product should be stored in a well-ventilated, cool and dry location.
  4. Disclose ingestion as a route of entry.
  5. Disclose that an ingredient has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
  6. Disclose an LD50 (dermal, rabbit) value of 8.00 mL/kg for the hazardous ingredient “isopropanol”.

RN: 8928 Date: 2014-11-03

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that the controlled product has been shown to cause eye and skin corrosion.
  2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that medical attention must be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed and that medical attention must be obtained immediately.
  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and that medical attention must be obtained immediately.

RN: 8929 Date: 2014-11-27

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the WHMIS classification D1A, if the WHMIS classifications are stated on the MSDS, and the WHMIS D1 pictogram, if WHMIS pictograms are shown on the MSDS.
  2. Disclose that the controlled product has been shown to be corrosive.
  3. Disclose that inhalation of the hazardous ingredient “sulfuric acid” has been shown to cause acute toxicity leading to death in laboratory animals.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
  5. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed and that medical attention must be obtained immediately.
  6. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and medical attention must be obtained immediately.

RN: 8930 Date: 2014-10-14

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Add oxides of nitrogen to the list of hazardous combustion products.
  3. Disclose the skin notation for the ACGIH TLV–TWA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  4. Disclose ingestion as a route of entry.

RN: 8931 Date: 2014-09-30

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose on the MSDS the presence of an additional confidential hazardous ingredient, “borate salts”, together with its percent concentration, in an acceptable manner.
  2. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

RN: 8933 Date: 2014-09-09

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.
  2. Add oxides of carbon, oxides of nitrogen and hydrogen chloride to the list of hazardous decomposition products.

RN: 8934 Date: 2014-09-15

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed.
  2. Disclose ingestion as a route of entry.
  3. Disclose the LD50 (dermal, rabbit) values for the hazardous ingredients or a value for the product in an acceptable manner.

RN: 8935 Date: 2014-09-22

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. Disclose the LD50 (dermal, rabbit) values for the hazardous ingredients or a value for the product in an acceptable manner.

RN: 8937 Date: 2014-08-20

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
  2. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
  3. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed.
  4. In relation to the first aid information shown on the MSDS for ingestion, remove the advice to induce vomiting and to give two glasses of water to drink. Disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  5. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source and that the product should be stored in a well-ventilated, cool and dry location.
  6. Disclose the skin notation for the ACGIH TLV–TWA and OSHA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  7. Disclose ingestion as a route of entry.

RN: 8938 Date: 2014-08-20

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.
  2. Disclose the AIHA WEEL–TWA Exposure Limit value of 10 mg/m3 for the hazardous ingredient “propylene glycol”.

RN: 8940 Date: 2014-09-26

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that the controlled product has been shown to cause eye corrosion.
  2. Disclose the presence of two additional hazardous ingredients, “polyoxylated fatty amine salt” and “2-benzylisoquinolinium chloride”, together with their chemical identities, percent concentrations and CAS registry numbers, in an acceptable manner
  3. Disclose the presence of three additional confidential hazardous ingredients, “fatty acids, tall oil”, “cycloaliphatic alkoxylate” and “alkyl amine blend in a metal salt solution”, together with their generic chemical identities and percent concentrations, in an acceptable manner.
  4. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes.
  5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose advice such as the following: trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  6. Add hydrogen chloride to the list of hazardous combustion products.
  7. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source and that the product should be stored in a well-ventilated, cool and dry location.
  8. Disclose the skin notation for the ACGIH TLV–TWA and OSHA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  9. Disclose ingestion as a route of entry.
  10. Disclose that the hazardous ingredients have been shown to cause skin sensitization in laboratory animals.
  11. Disclose that an ingredient has been shown to cause mutagenic effects in bacterial and in mammalian cells, in vitro.
  12. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “aldehyde” in an acceptable manner.
  13. Disclose an LD50 (dermal, rabbit) value of 6.28 g/kg for the hazardous ingredient “isopropanol”.

RN: 8941 Date: 2014-08-20

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose on the MSDS the presence of an additional confidential hazardous ingredient, “fatty acids, ethoxylated”, together with its generic chemical identity and percent concentration, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Add oxides of nitrogen to the list of hazardous combustion products.
  4. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source and that the product should be stored in a well-ventilated, cool and dry location.
  5. Disclose ingestion as a route of entry.
  6. Disclose that an ingredient has been shown to cause teratogenic/embryotoxic effects in the presence of maternal toxicity in laboratory animals.
  7. Disclose an LD50 (dermal, rabbit) value of 6 280 mg/kg for the hazardous ingredient “isopropanol”.

RN: 8942 Date: 2014-09-30

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the generic chemical identity and percent concentration for the confidential hazardous ingredients “fatty acids, ethoxylated” and “ketone” in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Add oxides of nitrogen to the list of hazardous combustion products.
  4. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source.
  5. Disclose the skin notation for the ACGIH TLV–TWA Exposure Limit and the OSHA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  6. Disclose ingestion as a route of entry.
  7. Disclose that an ingredient has been classified as a Group 2B carcinogen by the International Agency for Research on Cancer (IARC).
  8. Disclose an LD50 (dermal, rabbit) value of 6.28 g/kg for the hazardous ingredient “isopropanol”.

RN: 8943 Date: 2014-09-26

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose that the controlled product has been shown to cause eye corrosion.
  2. Disclose the presence of three additional hazardous ingredients, together with their chemical identities, percent concentration and CAS registry numbers, in an acceptable manner.
  3. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  5. Add oxides of nitrogen to the list of hazardous combustion products.
  6. Disclose the skin notation for the ACGIH TLV–TWA Exposure Limit and the OSHA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  7. Disclose ingestion as a route of entry.
  8. Disclose that chronic inhalation of an ingredient has been shown to cause neoplastic adenomas in laboratory animals.
  9. Disclose that an ingredient has been shown to cause skin sensitization in laboratory animals.
  10. Disclose that an ingredient has been shown to cause mutagenic effects in mammalian cells, in vitro.
  11. Disclose an LC50 (vapour, female rat, 4 hours) value of 520 ppm for the hazardous ingredient “propargyl alcohol”.

RN: 8944 Date: 2014-09-15

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.
  3. Add oxides of nitrogen and hydrogen chloride to the list of hazardous combustion products.

RN: 8945 Date: 2014-09-15

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Disclose ingestion as a route of entry.

RN: 8946 Date: 2014-09-17

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the WHMIS classification E, if the WHMIS classifications are stated on the MSDS, and the WHMIS E pictogram, if WHMIS pictograms are shown on the MSDS.
  2. Disclose that the controlled product has been shown to cause eye corrosion.
  3. In relation to the first aid information shown on the MSDS for eye contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  4. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 30 minutes and a statement to the effect that contaminated clothing, shoes and leather goods should be removed and medical attention must be obtained immediately.
  5. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and medical attention must be obtained immediately.
  6. Disclose ingestion as a route of entry.

RN: 8947 Date: 2014-09-30

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LC50 (aerosol, rat, 4 hours) value for the confidential hazardous ingredient “paraffinic solvent” in an acceptable manner.

RN: 8948 Date: 2014-08-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, “ethoxylated amines blend”, together with its percent concentration, in an acceptable manner.
  2. Disclose the percent concentration for the confidential hazardous ingredient “alkyl amine blend in a metal salt solution” in an acceptable manner.
  3. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  5. Add oxides of nitrogen to the list of hazardous combustion products.
  6. Disclose the skin notation for the ACGIH TLV–TWA Exposure Limit for the hazardous ingredients “ethanolamine” and “dibutylaminoethanol” in an acceptable manner.
  7. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 8949 Date: 2014-08-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the advice to induce vomiting and to give two glasses of water to drink. Disclose advice such as the following: trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  2. Disclose the skin notation for the OSHA PEL–TWA Exposure Limit for the hazardous ingredient “ethylene glycol monobutyl ether” in an acceptable manner.
  3. Disclose ingestion as a route of entry.
  4. Disclose that an ingredient has been classified as a suspected human carcinogen (A3) by the ACGIH.

RN: 8950 Date: 2014-10-30

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the WHMIS classification D1A, if the WHMIS classifications are stated on the MSDS, and the WHMIS D1 pictogram, if WHMIS pictograms are shown on the MSDS.
  2. Disclose the presence of an additional hazardous ingredient, “ethoxylated alcohol”, together with its percent concentration, in an acceptable manner.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source and that metal containers should be grounded during the transfer of large quantities of the controlled product.
  5. Disclose an OSHA PEL–TWA Exposure Limit of 50 ppm, with a skin notation, for the hazardous ingredient “ethylene glycol monobutyl ether”.
  6. Disclose ingestion as a route of entry.
  7. Disclose that acute dermal exposure to an ingredient has been shown to cause hemolysis via dermal exposure in laboratory animals.
  8. Disclose that chronic ingestion of an ingredient has been shown to cause hearing loss in laboratory animals.
  9. Disclose that an ingredient has been classified as a suspected human carcinogen (A3) by the ACGIH.
  10. Disclose that an ingredient reacts synergistically with “acetylsalicylic acid” and “n-hexane” to produce irreversible auditory damage.
  11. Disclose an acceptable LD50 (oral, rat) value for the confidential hazardous ingredient “ethoxylated alcohol”.

RN: 8951 Date: 2014-09-23

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
  2. Disclose the presence of two additional confidential hazardous ingredients, “ethoxylated alcohol” and “alcohol”, in an acceptable manner.
  3. Disclose the presence of an additional hazardous ingredient, “methanol”, together with its percent concentration and CAS registry number, in an acceptable manner.
  4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink and disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  5. Disclose the skin notation for the OSHA PEL–TWA Exposure Limit for the hazardous ingredient “ethylene glycol monobutyl ether” in an acceptable manner.
  6. Disclose an ACGIH TLV–TWA Exposure Limit of 100 mg/m3 (ceiling) for the hazardous ingredient “ethylene glycol”.
  7. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 250 ppm, both with a skin notation, for the hazardous ingredient “methanol”.
  8. Disclose ingestion as a route of entry.
  9. Disclose that the hazardous ingredient “ethylene glycol monobutyl ether” has been shown to cause red blood cell hemolysis in laboratory animals.
  10. Disclose that an ingredient has been classified as a suspected animal carcinogen (A3) by the ACGIH.
  11. Disclose that an ingredient has been shown to cause teratogenic effects in laboratory animals.
  12. Disclose an LD50 (oral, rat) value and an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “alcohol” in an acceptable manner.

RN: 8953 Date: 2014-10-15

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the advice to induce vomiting and to give two glasses of water to drink.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  3. Disclose an ACGIH TLV–TWA Exposure Limit of 100 mg/m3 (aerosol only) for the hazardous ingredient “ethylene glycol”.
  4. Disclose ingestion as a route of entry.
  5. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “ethoxylated nonylphenol” in an acceptable manner.

RN: 8954 Date: 2014-10-15

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the advice to induce vomiting and to give two glasses of water to drink. Disclose advice such as the following: trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Disclose the skin notation for the ACGIH TLV–TWA Exposure Limit for the hazardous ingredient “methanol” in an acceptable manner.
  4. Disclose an OSHA PEL–TWA Exposure Limit, with a skin notation, for the hazardous ingredient “ethylene glycol monobutyl ether” in an acceptable manner.
  5. Disclose ingestion as a route of entry.
  6. Disclose an LD50 (oral, rat) value of 510 mg/kg for the hazardous ingredient “poly(oxy-1,2-ethandiyl), α-(nonylphenyl)-ω-hydroxy-”.

RN: 8955 Date: 2014-10-17

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional confidential hazardous ingredient, “ethoxylated fatty acids”, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.

RN: 8956 Date: 2014-10-27

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of two additional confidential hazardous ingredients, “alky aryl sulfonate” and “ethoxylated fatty acids”, in an acceptable manner.
  2. Add oxides of sulphur to the list of hazardous combustion products.

RN: 8957 Date: 2014-09-04

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.

RN: 8958 Date: 2014-10-06

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. Disclose that an ingredient has been shown to cause hemolysis via ingestion, inhalation and dermal exposure in laboratory animals.
  3. Disclose the presence of two additional confidential hazardous ingredients, “phosphoric acid esters” and “oxyalkylated polymer”, in an acceptable manner.
  4. Disclose an acceptable LD50 (dermal, male rabbit) value for the confidential hazardous ingredient “organic sulphur compound”.
  5. Disclose an acceptable LD50 (oral, rat) value for the confidential hazardous ingredient “oxyalkylate”.
  6. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped and that medical attention must be obtained immediately.
  7. Add oxides of nitrogen, oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.
  8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

RN: 8963 Date: 2014-10-07

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. Disclose an LD50 (dermal, rabbit) value of 40–200 mg/kg for the confidential hazardous ingredient “organic sulphur compound”.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  4. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

RN: 8965 Date: 2014-09-03

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for inhalation, disclose advice such as the following: medical attention must be obtained immediately.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.

RN: 8966 Date: 2014-08-26

The claimant had been advised to amend certain aspects of the content and format of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 2 040 mg/kg for the confidential hazardous ingredient “alcohol II”.
  2. Disclose that acute inhalation of an ingredient has been shown to cause central nervous system effects in laboratory animals.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.
  4. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes.

RN: 8967 Date: 2014-09-30

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of the additional hazardous ingredient “ethylene glycol”, together with its chemical identity, percent concentration and CAS registry number, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes.
  3. Disclose an ACGIH TLV–C Exposure Limit of 100 mg/m3 (aerosol only) for the hazardous ingredient “ethylene glycol”.
  4. Disclose that oral exposure to the hazardous ingredient “ethylene glycol” has been shown to cause fetotoxic effects in the absence of maternal toxicity in laboratory animals.

RN: 8968 Date: 2014-09-30

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, “ethylene glycol”, together with its percent concentration and CAS registry number, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes.
  3. Disclose an ACGIH TLV–C Exposure Limit of 100 mg/m3 (aerosol only) for the hazardous ingredient “ethylene glycol”.
  4. Disclose that oral exposure to the hazardous ingredient “ethylene glycol” has been shown to cause fetotoxic effects in the absence of maternal toxicity in laboratory animals.

RN: 8969 Date: 2014-11-20

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause hemolysis via ingestion, inhalation and dermal exposure in laboratory animals.
  2. Disclose that exposure to hazardous ingredient “2-butoxyethanol” has been shown to cause fetotoxic effects in the presence of maternal toxicity in laboratory animals.
  3. Disclose the presence of two additional confidential hazardous ingredients, “carboxylic acid-polyamine condensate” and “phosphoric acid esters”, in an acceptable manner.
  4. Disclose an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “organic sulphur compound” in an acceptable manner.
  5. Add oxides of nitrogen, oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.

RN: 8970 Date: 2014-11-21

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of two additional hazardous ingredients, “mineral oil” and “cationic polymer”, together with their percent concentrations and CAS registry numbers, in an acceptable manner.
  2. Disclose an LD50 (oral, rat) value and an LD50 (dermal, rabbit) value for the confidential hazardous ingredient “ethoxylated nonyl phenol” in an acceptable manner.
  3. Disclose that an ingredient has been shown to cause teratogenic and embryotoxic effects in the presence of maternal toxicity in laboratory animals.

RN: 8971 Date: 2014-09-29

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. Disclose the presence of three additional confidential hazardous ingredients, “oxyalkylate polymer”, “organic sulfonic acid amine salt 1” and “organic sulfonic acid amine salt 2”, in an acceptable manner.
  3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8972 Date: 2014-09-15

The claimant had been advised to amend the MSDS as indicated below.

  1. Add hydrogen chloride to the list of hazardous combustion products.

RN: 8973 Date: 2014-09-26

The claimant had been advised to amend certain aspects of the content and format of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that the controlled product has been shown to cause eye and skin corrosion.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes and that medical attention must be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and medical attention must be obtained immediately.
  4. Add oxides of nitrogen to the list of hazardous combustion products.
  5. Disclose that an ingredient has been shown to cause skin sensitization in laboratory animals.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

RN: 8975 Date: 2014-10-07

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Add hydrogen chloride to the list of hazardous combustion products.

RN: 8977 Date: 2014-11-03

The claimant had been advised to amend certain aspects of the content and wording of the MSDS.

RN: 8978 Date: 2014-10-27

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one to two glasses of water or milk to drink.
  2. Add hydrogen chloride to the list of hazardous combustion products.
  3. Disclose that an ingredient has been shown to cause respiratory sensitization and development of asthma-like symptoms.
  4. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro.

RN: 8979 Date: 2014-11-03

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.
  2. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  3. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one glass of water or milk to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.
  4. Disclose a statement to the effect that if ventilation is inadequate, vapours can spread from open containers of the product and may flash back, causing a fire, if they come into contact with an ignition source.

RN: 8980 Date: 2014-11-03

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one glass of water or milk to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration.

RN: 8981 Date: 2014-11-10

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LC50 (dust, rat, 1 hour) value for the hazardous ingredient “silica, amorphous precipitated” in an acceptable manner.

RN: 8982 Date: 2014-11-05

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause hemolysis via ingestion, inhalation and dermal exposure in laboratory animals.
  2. Disclose the presence of two additional hazardous ingredients, “phosphoric acid esters” and “carboxylic acid-polyamine condensate”, together with their percent concentrations and CAS registry numbers, in an acceptable manner.
  3. Disclose an LC50 (vapour, female rat, 6 hours) value of 23.9 mg/L for the hazardous ingredient “heavy catalytic reformed naphtha”.
  4. Disclose an LD50 (dermal, male rabbit) value for the confidential hazardous ingredient “organic sulfur compound” in an acceptable manner.
  5. Add oxides of nitrogen, oxides of sulphur and hydrogen chloride to the list of hazardous combustion products.

RN: 8983 Date: 2014-11-18

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose ingestion as a route of entry.
  2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.
  3. Add oxides of nitrogen to the list of hazardous combustion products.
  4. Disclose a statement to the effect that metal containers should be grounded during the transfer of large quantities of the controlled product.
  5. Disclose an ACGIH TLV–TWA Exposure Limit of 200 ppm and an ACGIH TLV–STEL Exposure Limit of 400 ppm for the hazardous ingredient “isopropanol”.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class B2.

RN: 8984 Date: 2014-09-03

The claimant had been advised to amend the MSDS as indicated below.

  1. Add oxides of carbon and oxides of nitrogen to the list of hazardous combustion products.

RN: 8992 Date: 2014-09-17

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, together with its chemical identity, percent concentration and CAS registry number, in an acceptable manner.

RN: 8993 Date: 2014-09-17

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, together with its percent concentration and CAS registry number, in an acceptable manner.
  2. Add hydrogen chloride to the list of hazardous decomposition products on the MSDS.

RN: 8994 Date: 2014-09-26

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the percent concentration for the confidential hazardous ingredient “polyol acrylate” in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes.
  3. Disclose the AIHA WEEL–TWA Exposure Limit value of 1 mg/m3 for the hazardous ingredient “pentaerythritol triacrylate”.
  4. Disclose an LD50 (dermal, rabbit) value of 4.60 g/kg for the hazardous ingredient “pentaerythritol triacrylate”.
  5. Disclose that an ingredient has been shown to cause mutagenic effects in mammalian cells, in vitro.

RN: 8995 Date: 2014-09-26

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, together with its chemical identity, percent concentration and CAS registry number, in an acceptable manner.

RN: 8996 Date: 2015-01-22

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose an ACGIH TLV–TWA Exposure Limit of 1 mg/m3 and an ACGIH TLV–STEL Exposure Limit of 3 mg/m3 for the hazardous ingredient “phosphoric acid”.

RN: 9000 Date: 2014-11-19

The claimant had been advised to amend the MSDS as indicated below.

  1. Disclose the AIHA WEEL–TWA Exposure Limit value of 1 mg/m3 for the hazardous ingredient “pentaerythritol triacrylate”.
  2. Disclose an LD50 (dermal, rabbit) value of 4.60 g/kg for the hazardous ingredient “pentaerythritol triacrylate”.
  3. Disclose that an ingredient has been shown to cause mutagenic effects in mammalian cells, in vitro.

RN: 9001 Date: 2014-10-07

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes.
  2. Add oxides of nitrogen to the list of hazardous combustion products.
  3. Disclose that an ingredient has been shown to cause mutagenic effects in mammalian cells and bacterial cells, in vitro, in the presence and absence of metabolic activation.

RN: 9004 Date: 2014-10-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of an additional hazardous ingredient, together with its chemical identity, percent concentration and CAS registry number, in an acceptable manner.
  2. Add hydrogen chloride to the list of hazardous combustion products.
  3. Disclose a LD50 (oral, rat) value of 1 220 mg/kg for the hazardous ingredient “ammonium chloride”.

RN: 9005 Date: 2014-10-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add hydrogen chloride to the list of hazardous combustion products.
  2. Disclose a LD50 (oral, rat) value of 1 220 mg/kg for the hazardous ingredient “ammonium chloride”.

RN: 9007 Date: 2014-12-17

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add hydrogen chloride to the list of hazardous decomposition products on the MSDS.

CLAIMS FOR WHICH THE SCREENING OFFICER ORDERED THE CLAIMANT TO COMPLY WITH THE APPLICABLE DISCLOSURE REQUIREMENTS

In the case of the following claims, either the claimant did not supply the screening officer with a signed undertaking or the screening officer was not satisfied that the claimant had taken the measures set out in the undertaking in the manner and within the period specified in it. Pursuant to subsection 17(1) of the Hazardous Materials Information Review Act, the screening officer ordered the claimant to comply with the requirements of the relevant legislation within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 30 days of expiry of the appeal period.

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that the screening officer ordered to be disclosed on an MSDS or label reviewed by the screening officer and the date of the order.

RN: 8503 Date: 2014-11-28

The claimant had been advised to amend certain aspects of the content and format of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value for a component of the confidential hazardous ingredient “urethane methacrylate resin” in an acceptable manner.
  2. Disclose that an ingredient is incompatible with “aniline, N,N-dimethylaniline, dimethyl sulfide and vinyl acetate”.
  3. Disclose ingestion as a route of entry.
  4. Disclose that all hazardous ingredients have been shown to cause skin sensitization in laboratory animals.
  5. Disclose that an ingredient has been shown to cause mutagenic effects, in vitro, and teratogenic effects in laboratory animals.
  6. Disclose that an ingredient has been shown to cause reproductive effects in laboratory animals.
  7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

RN: 8841 Date: 2014-08-13

The claimant had been advised to amend certain aspects of the wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose that an ingredient has been shown to cause hemolysis via ingestion, inhalation and dermal exposure in laboratory animals.
  2. Disclose a WHMIS acceptable concentration range for the confidential hazardous ingredient “siloxanes”.
  3. Disclose an LD50 (oral, female rat) value of 530 mg/kg, an LD50 (dermal, rabbit) value of 0.45 mL/kg, and an LC50 (vapour, rat, 4 hours) value of 450 ppm for the hazardous ingredient “butoxyethanol, 2-”.
  4. Disclose an LD50 (oral, rat) value of 12.2 g/kg for the hazardous ingredient “coconut oil diethanolamide”.
  5. Disclose an LD50 (dermal, rabbit) value of 8.00 mL/kg for the hazardous ingredient “propanol, 2-”.
  6. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1A.

RN: 8859 Date: 2014-10-20

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Add hydrogen chloride to the list of hazardous combustion products.
  2. Disclose that an ingredient is an eye irritant in laboratory animals.
  3. Disclose that the confidential hazardous ingredient “alkylamines” has been shown to cause mutagenic effects in bacteria, in vitro.

RN: 8884 Date: 2014-09-09

The claimant had been advised to amend certain aspects of the content and wording of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the presence of two additional hazardous ingredients, together with their chemical identities, percent concentrations and CAS registry numbers, in an acceptable manner.
  2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one glass of water to drink and disclose advice such as the following: should vomiting occur naturally, have the casualty lean forward in order to reduce the risk of aspiration and medical attention must be obtained immediately.
  3. In relation to the first aid information shown on the MSDS for eye and skin contact, disclose an approximate flush time of 30 minutes.
  4. Disclose that the controlled product has been shown to cause eye and skin corrosion.
  5. Disclose an LD50 (oral, rat) value for the confidential hazardous ingredient “long-chain alkenyl amine” in an acceptable manner.
  6. Disclose an LD50 (oral, rat) value of 1 400 mg/kg for the confidential hazardous ingredient “alkyl phosphate”.
  7. Disclose an LD50 (oral, rat) value of 2 710 mg/kg for the hazardous ingredient “phosphoric acid, mono(2-ethylhexyl) ester”.
  8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class E.

CLAIMS FOR WHICH THE SCREENING OFFICER ISSUED THE DECISION THAT THE CLAIM FOR EXEMPTION WAS EITHER PARTIALLY VALID OR INVALID

In the case of the following claims, the screening officer issued the decision that the claim for exemption was invalid.

Pursuant to section 18 of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of information that the screening officer ordered to be disclosed on an MSDS or label pursuant to subsection 16(1) and information that has been disclosed on the relevant MSDS or label in compliance with an undertaking, and the dates on which the orders and notices referred to in subsection 16.1(3) of the Act were issued.

RN: 8682

Date of order: 2014-07-03

The claimant had been advised to amend certain aspects of the content of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose the chemical identity, CAS registry number and concentration of the ingredient for which the claim was made and found to be invalid.

Date of compliance undertaking: 2014-07-22

The claimant had been advised to amend the MSDS as indicated below.

  1. In relation to the first aid information shown on the MSDS for skin contact, disclose an approximate flush time of 15–20 minutes and that medical attention must be obtained immediately.
  2. Disclose that the ingredient for which the claim was made and found to be invalid is a skin irritant.

RN: 8908

Date of order: 2014-07-09

The claimant had been advised to amend certain aspects of the content of the MSDS.

Date of compliance undertaking: 2014-07-14

The claimant had been advised to amend certain aspects of the format of the MSDS and had been further advised to amend the MSDS as indicated below.

  1. Disclose an LD50 (oral, rat) value of 7 050 mg/kg for the hazardous ingredient “solvent naphtha (petroleum), heavy arom”.

[13-1-o]

DEPARTMENT OF INDUSTRY

RADIOCOMMUNICATION ACT

Notice No. SMSE-005-15 — Release of RSS-102, Issue 5

Notice is hereby given that Industry Canada is releasing the following document:

General information

RSS-102, Issue 5, takes effect immediately for the purposes of certifying new equipment. All devices currently certified that are manufactured, imported or sold in Canada must be in compliance with the revised standard 180 days after its publication on the Industry Canada Web site — no matter when they were originally certified. Some requirements will not be in force immediately, as outlined in Notice 2015-DRS001 available at http://www.ic.gc.ca/eic/site/ceb-bhst.nsf/eng/h_tt00080.html.

RSS-102 has been coordinated with industry through the Radio Advisory Board of Canada (RABC). The equipment and radio apparatus standards lists will be amended to reflect any changes or revisions to the document.

Submitting comments

Interested parties are requested to provide their comments in electronic format (Microsoft Word or Adobe PDF) to the Manager, Radio Equipment Standards (res.nmr@ic.gc.ca) within 90 days of the publication date of this notice.

Obtaining copies

Copies of this notice and of documents referred to herein are available electronically on Industry Canada's Spectrum Manage-ment and Telecommunications Web site at http://www.ic.gc.ca/spectrum.

Official versions of Canada Gazette notices can be viewed at http://www.gazette.gc.ca/rp-pr/p1/index-eng.html.

March 13, 2015

DANIEL DUGUAY
Director General
Engineering, Planning and Standards Branch

[13-1-o]

DEPARTMENT OF INDUSTRY

RADIOCOMMUNICATION ACT

Notice No. SMSE-006-15 — Release of new issue of BPR-1

Notice is hereby given that Industry Canada is publishing Issue 6 of Broadcasting Procedures and Rules, Part 1 (BPR-1), General Rules. The new issue provides updates to the requirements for assessing exposure to radio frequency (RF) energy, as well as a revised methodology for evaluating compliance with the limits of human exposure to RF electromagnetic energy for AM broadcasting undertakings.

Several editorial changes have also been made throughout the document.

General information

This document has been coordinated with industry through the Radio Advisory Board of Canada (RABC).

Submitting comments

Interested parties are requested to provide their comments within 60 days of the date of publication of this notice in electronic format (Microsoft Word or Adobe PDF) to the Manager, Broadcast and Multimedia Engineering (broadcast.gazette@ic.gc.ca).

Written submissions should be addressed to the Director General, Engineering, Planning and Standards Branch, Industry Canada, 235 Queen Street, Ottawa, Ontario K1A 0H5. All submissions should cite the Canada Gazette, Part I, the publication date, the title and the notice reference number (SMSE-006-15).

Obtaining copies

Copies of this notice and of documents referred to herein are available electronically on Industry Canada's Spectrum Manage-ment and Telecommunications Web site at http://www.ic.gc.ca/spectrum.

Official versions of Canada Gazette notices can be viewed at http://www.gazette.gc.ca/rp-pr/p1/index-eng.html.

March 19, 2015

DANIEL DUGUAY
Director General
Engineering, Planning and Standards Branch

[13-1-o]

DEPARTMENT OF INDUSTRY

TRADE-MARKS ACT

Geographical indications

The Minister of Industry proposes that the following geographical indications be entered on the list of geographical indications kept pursuant to subsection 11.12(1) of the Trade-marks Act, where “(i)” refers to the file number, “(ii)” refers to the indication and whether it identifies a wine or spirit, “(iii)” refers to the territory, or the region or locality of a territory in which the wine or spirit is identified as originating, “(iv)” refers to the name of the responsible authority (the person, firm or other entity that is, by reason of state or commercial interest, sufficiently connected with and knowledgeable about the wine or spirit), “(v)” refers to the address in Canada for the responsible authority, and “(vi)” refers to the quality, reputation or other characteristic of the wine or spirit that, in the opinion of the Minister, qualifies that indication as a geographical indication:

[13-1-o]

DEPARTMENT OF TRANSPORT

CANADA MARINE ACT

Québec Port Authority — Supplementary letters patent

BY THE MINISTER OF TRANSPORT

WHEREAS letters patent were issued by the Minister of Transport for the Québec Port Authority (“Authority”), under the authority of the Canada Marine Act (“Act”), effective May 1, 1999;

WHEREAS Schedule B of the letters patent sets out the federal immovables under the management of the Authority;

WHEREAS the federal immovable known and designated as being lot 4 724 184 of the Cadastre of Quebec (“Immovable”) forming part of walls critical to the integrity of Bassin Louise, a harbour area of the port of Québec, is under the administration of the Minister of Public Works and Government Services;

WHEREAS the Minister of Public Works and Government Services has agreed to transfer the administration of the Immovable to the Minister of Transport in order for the Minister of Transport to give management of the Immovable to the Authority;

WHEREAS, pursuant to section 9 of the Act, the Minister of Transport wishes to issue, on her own initiative, supplementary letters patent to the Authority to give management of the Immovable to the Authority;

WHEREAS, pursuant to the same section of the Act, notice of the proposed changes to the Authority's letters patent was given in writing to the board of directors of the Authority, to which the Authority indicated the board of directors is in support of the proposed changes;

AND WHEREAS the Minister of Transport is satisfied that the amendment to the letters patent is consistent with the Act;

NOW THEREFORE, pursuant to subsection 9(1) of the Act, the letters patent are amended as follows:

1. Schedule B of the letters patent is amended by adding the following to the end of section 3 of Part (B):
Lot Description
4 724 184 An immovable known and designated as being lot 4 724 184 of the Cadastre of Quebec, Registration Division of Québec, City of Québec, as described in certificate of location and shown on the accompanying plan prepared January 31, 2012, under number 3694 of the minutes of Mr. Martin Pageau, land surveyor, containing an area of 1707.9 m2, excluding the market kiosk owned by the City of Québec, Subject to servitudes established by Her Majesty the Queen in right of Canada (Minister of Public Works and Government Services) with private deed, dated March 7, 2013, a copy of which was registered in the Land register of Quebec, Registration Division of Québec, on March 11, 2013, under number 19 787 726.

2. These supplementary letters patent take effect at the effective date of the Transfer of Administration between ministers relating to the Immovable.

ISSUED this 27th day of February, 2015.

________________________________
The Honourable Lisa Raitt, P.C., M.P.
Minister of Transport

[13-1-o]

DEPARTMENT OF TRANSPORT

CANADA MARINE ACT

Trois-Rivières Port Authority — Supplementary letters patent

BY THE MINISTER OF TRANSPORT

WHEREAS letters patent were issued by the Minister of Transport (“Minister”) for the Trois-Rivières Port Authority (“Authority”), under the authority of the Canada Marine Act (“Act”), effective May 1, 1999;

WHEREAS Schedule B of the letters patent sets out the federal immovables managed by the Authority, and includes the federal immovable known and described as being lot 1 018 484 (“Immovable”) of the cadastre of Quebec;

WHEREAS pursuant to subparagraph 46(1)(b)(i) of the Act, the Authority wishes to exchange the Immovable for other immovables of comparable value, being immovables known and described as lots 1 018 711, 1 018 714, 1 019 102 and 4 970 632 of the cadastre of Quebec, belonging to the City of Trois-Rivières;

WHEREAS the board of directors of the Authority has requested that the Minister issue supplementary letters patent to amend Schedule B of its letters patent to reflect the said exchange of immovables;

AND WHEREAS the Minister is satisfied that the amendments to the letters patent of the Authority are consistent with the Act,

NOW THEREFORE, pursuant to subsection 9(1), the letters patent are amended as follows:

1. Schedule B of letters patent is amended by deleting the following:

Description of immovable property acquired as Federal real property and managed by the Trois-Rivières Port Authority and nature of the act of transfer of ownership.

Nature of the Act of Transfer of ownership Name and Capacity of Parties Description of Immovable Acquired
Deed of Sale 9094-1659 QUÉBEC INC., Seller Her Majesty the Queen in right of Canada represented by the minister of Transport, Buyer Immovable known and described as being Lot number one million eighteen thousand four hundred and eighty-four (Lot 1,018,484) of the Cadastre of Quebec, Registration Division of Trois-Rivières. With buildings thereon erected bearing civic numbers 31-45, de la Fosse Street, in Trois-Rivières. All as shown in the certificate of location prepared by Pierre Brodeur, land surveyor, dated August 30, 2000 under number 3930 of his minutes (file: 00-411).
2. Schedule B of the letters patent is amended by adding the following to the end of list of immovables in section 1 under the heading “Municipality: Trois-Rivières”:
Lot Number Description
1 018 711 An immovable known and described as being lot 1 018 711 of the cadastre of Quebec, Registration Division of Trois-Rivières, city of Trois-Rivières, as described in the certificate of location and shown on the accompanying plan prepared April 23, 2012, under number 2752 of the minutes of Michel Plante, land surveyor, containing an area of 1259.0 m2.
1 018 714 An immovable known and described as being lot 1 018 714 of the cadastre of Quebec, Registration Division of Trois-Rivières, city of Trois-Rivières, as described in the certificate of location and shown on the accompanying plan prepared April 23, 2012, under number 2751 of the minutes of Michel Plante, land surveyor, containing an area of 385.3 m2.
1 019 102 An immovable known and described as being lot 1 019 102 of the cadastre of Quebec, Registration Division of Trois-Rivières, city of Trois-Rivières, as described in the certificate of location and shown on the accompanying plan prepared August 31, 2011, under number 2582 of the minutes of Michel Plante, land surveyor, containing an area of 426.2 m2.
4 970 632 An immovable known and described as being lot 4 970 632 of the cadastre of Quebec, Registration Division of Trois-Rivières, city of Trois-Rivières, as described in the certificate of location and shown on the accompanying plan prepared April 23, 2012, under number 2752 of the minutes of Michel Plante, land surveyor, containing an area of 318.5 m2.

3. These supplementary letters patent take effect on the date of issuance.

ISSUED under my hand this 18th day of February, 2015.

_______________________________
The Honourable Lisa Raitt, P.C., M.P.
Minister of Transport

[13-1-o]

DEPARTMENT OF TRANSPORT

CANADA MARINE ACT

Vancouver Fraser Port Authority — Supplementary letters patent

BY THE MINISTER OF TRANSPORT

WHEREAS the Governor in Council, pursuant to Part 5.1 of the Port Authorities Management Regulations, issued a Certificate of Amalgamation containing letters patent to amalgamate the Vancouver Port Authority, the Fraser River Port Authority and the North Fraser Port Authority to continue as the Vancouver Fraser Port Authority (“Authority”), effective January 1, 2008;

WHEREAS Schedule C of the letters patent sets out the real property, other than federal real property, held or occupied by the Authority;

WHEREAS, pursuant to subsection 46(2.1) of the Canada Marine Act (“Act”), the Authority entered into a licence agreement, as licensee, with the Tsawwassen First Nation to access the real property described below as a portion of PID number 027-863-514 (“Real Property”), for development and use of salt marsh fish habitat lands;

WHEREAS the Authority entered into a restrictive covenant agreement with the Tsawwassen First Nation to ensure that the Real Property remains as a salt marsh fish habitat area in its natural state for a period of sixty years from the date of signature of the covenant;

WHEREAS the board of directors of the Authority has requested that the Minister of Transport issue supplementary letters patent to include the interests in real property obtained by the Authority under the said agreements in Schedule C of the letters patent;

AND WHEREAS the Minister of Transport is satisfied that the amendment to the letters patent is consistent with the Act;

NOW THEREFORE, pursuant to subsection 9(1) of the Act, the letters patent are amended as follows:

1. Schedule C of the letters patent is amended by adding the following at the end of that Schedule:
Interest Lands to which interest relates
Licence for use of real property and associated restrictive covenant under the terms of a Licence Agreement and Convenant, both dated August 1, 2013 between the Tsawwassen First Nation and the Vancouver Fraser Port Authority That portion of PID number 027-863-514, Lot 1, District Lots 169 and 797, Group 2, New Westminster District, Plan BCP 38100, shown in heavy black outline on Reference Plan EPP30210
Access over real property under the terms of the Licence Agreement dated August 1, 2013 between the Tsawwassen First Nation and the Vancouver Fraser Port Authority PID: 027-863-514 Lot 1, District Lots 169 and 797, Group 2, New Westminster District, Plan BCP 38100 PID: 027-863-565 Lot 6 District Lots 169 and 797 Group 2 New Westminster District Plan BCP 38100

2. These supplementary letters patent take effect on the date of issuance.

ISSUED this 10th day of March, 2015.

________________________________
The Honourable Lisa Raitt, P.C., M.P.
Minister of Transport

[13-1-o]

BANK OF CANADA

Statement of financial position as at February 28, 2015

(Millions of dollars) Unaudited
ASSETS
Cash and foreign deposits   6.1
Loans and receivables
Securities purchased under resale agreements 703.5  
Advances to members of the Canadian Payments Association 1.4  
Advances to governments —  
Other receivables 2.9  
    707.8
Investments
Treasury bills of Canada 20,310.6  
Government of Canada bonds 71,547.6  
Other investments 381.9  
    92,240.1
Property and equipment   296.1
Intangible assets   42.4
Other assets   188.6
  93,481.1
LIABILITIES AND EQUITY
Bank notes in circulation   67,668.0
Deposits
Government of Canada 22,601.8  
Members of the Canadian Payments Association 578.5  
Other deposits 1,504.4  
    24,684.7
Liabilities in foreign currencies
Government of Canada —  
Other —  
    —
Other liabilities
Securities sold under repurchase agreements —  
Other liabilities 636.7  
    636.7
    92,989.4
Equity
Share capital 5.0  
Statutory and special reserves 125.0  
Available-for-sale reserve 361.7  
Actuarial gains reserve —  
Retained earnings —  
    491.7
93,481.1

I declare that the foregoing return is correct according to the books of the Bank.

Ottawa, March 13, 2015

Rudy Wytenburg
Deputy Chief — Financial Services

I declare that the foregoing return is to the best of my knowledge and belief correct, and shows truly and clearly the financial position of the Bank, as required by section 29 of the Bank of Canada Act.

Ottawa, March 13, 2015

Stephen S. Poloz
Governor

[13-1-o]